TREMFYA (guselkumab) injection
TREMFYA is a prescription medicine used for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. TREMFYA is indicated for the treatment of adult patients with active psoriatic arthritis. Brand Name: TREMFYA (guselkumab) injection, for subcutaneous use Initial U.S. Approval: 2017
Home | guselkumab injection
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
TREMFYA (guselkumab) injection
Guselkumab injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) or other treatments. Plaque psoriasis is a skin disease with red patches and white scales that do not go away.
TREMFYA is a prescription medicine used to treat adults:
• with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy
(treatment using ultraviolet or UV light)
• with active psoriatic arthritis (PsA).
It is not known if TREMFYA is safe and effective in children under 18 years of age
Guselkumab, sold under the brand name Tremfya, is a monoclonal antibody against interleukin-23 used for the treatment of plaque psoriasis. Active ingredient: guselkumab
Inactive ingredients: L-histidine, L-histidine monohydrochloride monohydrate, polysorbate 80, sucrose and water for injection Not made with natural rubber latex
Drug (Brand / Generic): TREMFYA / guselkumab
Current Indications: plaque psoriasis
Marketed by:: Janssen Biotech, Inc.
Approval Date: 2017
Dosage forms and strengths of TREMFYA (guselkumab) injection
Injection: 100 mg/mL in a single-dose prefilled syringe or single-dose One-Press patient-controlled injector
Find Reference Updates
Alleviare Life Sciences
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ TREMFYA (guselkumab) injection ”. Confirmation of the order for TREMFYA (guselkumab) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to Treatment – TREMFYA
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha